Literature DB >> 21258272

Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy.

David M Thompson1, Mark Meloche, Ziliang Ao, Breay Paty, Paul Keown, R Jean Shapiro, Stephen Ho, Dan Worsley, Michelle Fung, Graydon Meneilly, Iain Begg, Mohammed Al Mehthel, Joma Kondi, Claire Harris, Blake Fensom, Sharon E Kozak, Suet On Tong, Mary Trinh, Garth L Warnock.   

Abstract

BACKGROUND: The effect of islet cell transplantation (ICT) on the progression of diabetic microvascular complications is not well understood.
METHODS: We have conducted a prospective, crossover, cohort study comparing ICT with intensive medical therapy on the progression of diabetic nephropathy, retinopathy, and neuropathy.
RESULTS: The rate of decline in glomerular filtration rate is slower after ICT than on medical therapy. There was significantly more progression of retinopathy in medically treated patients than post-ICT. There was a nonsignificant trend for improved nerve conduction velocity post-ICT.
CONCLUSIONS: ICT is associated with less progression of microvascular complications than intensive medical therapy. Multicenter, randomized trials are needed to further study the role of ICT in slowing the progression of diabetic complications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258272     DOI: 10.1097/TP.0b013e31820437f3

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  63 in total

Review 1.  State of the art of clinical islet transplantation and novel protocols of immunosuppression.

Authors:  A M James Shapiro
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

2.  Transplantation: Sustained benefits of islet transplants for T1DM.

Authors:  Bernhard J Hering; Melena D Bellin
Journal:  Nat Rev Endocrinol       Date:  2015-08-04       Impact factor: 43.330

3.  Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.

Authors:  Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

Review 4.  Transplantation of xenogeneic islets: are we there yet?

Authors:  Philip J O'Connell; Peter J Cowan; Wayne J Hawthorne; Shounan Yi; Andrew M Lew
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

5.  Compensatory Islet Response to Insulin Resistance Revealed by Quantitative Proteomics.

Authors:  Abdelfattah El Ouaamari; Jian-Ying Zhou; Chong Wee Liew; Jun Shirakawa; Ercument Dirice; Nicholas Gedeon; Sevim Kahraman; Dario F De Jesus; Shweta Bhatt; Jong-Seo Kim; Therese Rw Clauss; David G Camp; Richard D Smith; Wei-Jun Qian; Rohit N Kulkarni
Journal:  J Proteome Res       Date:  2015-07-30       Impact factor: 4.466

Review 6.  Islet Transplantation Alone Versus Solitary Pancreas Transplantation: an Outcome-Driven Choice?

Authors:  Paola Maffi; Antonio Secchi
Journal:  Curr Diab Rep       Date:  2019-04-25       Impact factor: 4.810

Review 7.  Immunological Monitoring in Beta Cell Replacement: Towards a Pathophysiology-Guided Implementation of Biomarkers.

Authors:  Fanny Buron; Sophie Reffet; Lionel Badet; Emmanuel Morelon; Olivier Thaunat
Journal:  Curr Diab Rep       Date:  2021-04-25       Impact factor: 4.810

8.  How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology?

Authors:  Marco Carbone; Jan Lerut; James Neuberger
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 9.  Transplantation of Macroencapsulated Insulin-Producing Cells.

Authors:  Albert J Hwa; Gordon C Weir
Journal:  Curr Diab Rep       Date:  2018-06-16       Impact factor: 4.810

10.  Localized immune tolerance from FasL-functionalized PLG scaffolds.

Authors:  Michael Skoumal; Kyle B Woodward; Hong Zhao; Feng Wang; Esma S Yolcu; Ryan M Pearson; Kevin R Hughes; Andrés J García; Lonnie D Shea; Haval Shirwan
Journal:  Biomaterials       Date:  2018-11-13       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.